Patent ID: 9718886
Date: 2017-08-01
CPC Classifications: A61K,A61P,C07K

Claim:
1. A method of treating a patient having a tumor disease, wherein the cells of the tumor express claudin 6 (CLDN6), comprising the administration of (i) an antibody produced by a hybridoma deposited under the accession no. DSM ACC3059 (GT512muMAB 36A), DSM ACC3058 (GT512muMAB 27A), or DSM ACC3057 (GT512muMAB 5F2D2), (ii) a humanized or chimerized form of said antibody, (iii) an antigen binding fragment of said antibody, or (iv) a synthetic form of said antibody; capable of binding to CLDN6; wherein CLDN6 is SEQ ID NO: 2 or SEQ ID NO: 6, or wherein CLDN6 having amino acid sequence encoded by SEQ ID NO: 1; and wherein the antibody without an attached therapeutic effector moiety when administered to the patient inhibits growth of the tumor by binding to CLDN6.